Company Encyclopedia
View More
name
cbdMD
YCBD.US
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, ready to drink cans, and sleep, focus, and calming aids.
4.514 T
YCBD.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
PharmaceuticalsIndustry
Industry Ranking104/183
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-106.22%E
    • Profit Margin-7.96%D
    • Gross Margin61.45%A
  • Growth ScoreC
    • Revenue YoY-7.80%D
    • Net Profit YoY79.29%A
    • Total Assets YoY-28.52%E
    • Net Assets YoY101.79%A
  • Cash ScoreD
    • Cash Flow Margin-392.23%D
    • OCF YoY-7.80%D
  • Operating ScoreA
    • Turnover1.6A
  • Debt ScoreB
    • Gearing Ratio38.25%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Cbdmd Reports Preliminary Unaudited Fourth Quarter Results

    Nov 21 (Reuters) - cbdMD Inc (YCBD.A) :* CBDMD REPORTS PRELIMINARY UNAUDITED FOURTH QUARTER AND FISCAL 2025 RESULTS* CBDMD INC - EXPECTS FISCAL 2025 SALES REVENUE BETWEEN $19.1 AND $19.3 MILLION* CBDMD INC - EXPECTS Q4 FISCAL 2025 SALES REVENUE BETWEEN $4.7 AND $4.9 MILLION* CBDMD INC: EXPECT CONTINUED EARNINGS IMPROVEMENT FOR FISCAL 2025 OVER 2024 Source text: Further company coverage: (YCBD.A)

    Reuters·
    US
    YCBD
    +3.17%
    Reuters·
    US
    YCBD
    +3.17%

    cbdMD Reports Fiscal 2025 Net Sales of Up to $19.3 Million and Reduced Net Loss

    cbdMD Inc. reported preliminary unaudited financial results for fiscal 2025, with net sales expected between $19.1 million and $19.3 million, slightly down from $19.5 million in 2024. The fourth quarter sales are projected to rise 3% to 5% year-over-year. The company anticipates reducing its net loss to $1.9 million-$2.1 million, improving from a $3.7 million loss in 2024. cbdMD highlighted positive revenue growth and business model improvements.

    Reuters·
    US
    YCBD
    +3.17%
    Reuters·
    US
    YCBD
    +3.17%

    cbdMD's Herbal Oasis Hemp-Derived THC-Infused Social Seltzer Brand Expands its Product Offerings | YCBD Stock News

    cbdMD, Inc. (NYSE American: YCBD) has expanded its Herbal Oasis THC-infused social seltzer line with two new flavors: Berry Fusion and Tropic Wave, each containing 10mg of THC. This launch is based on consumer feedback and aims to provide a higher potency option for those seeking alternatives to alcohol during Sober October. The THC beverage market is projected to grow significantly, with U.S. sales reaching an estimated $1.1 billion in 2024. The new flavors are available at herbaloasis.com and select retail partners.

    StockTitan·
    US
    YCBD
    +3.17%
    StockTitan·
    US
    YCBD
    +3.17%

    U.S. Stock Market Midday Update: cbdMD up 10.95%

    cbdMD rose 10.95%; Eli Lilly fell 2.41%, with a trading volume of USD 2.09 billion; Johnson & Johnson rose 0.51%, with a trading volume of USD 845 million; Rani Therapeutics rose 299.24%, with a trading volume of USD 733 million; AstraZeneca rose 1.40%, with a market capitalization of USD 263.7 billion

    Tracking Unusual Activity·
    US
    YCBD
    +3.17%
    Tracking Unusual Activity·
    US
    YCBD
    +3.17%

    cbdMD partners with Bevtalk Distribution to expand in Florida; leading CBD brand in US with Farm Bill-compliant products.

    In Charlotte, North Carolina on October 9, 2025, cbdMD, Inc. revealed that it is listed on NYSE American under the ticker symbol YCBD. The company is a well-known CBD brand in the United States, offering a wide range of CBD products produced domestically. They also comply with the Farm Bill regulations for Delta-9 products.

    Unusual Whales·
    US
    YCBD
    +3.17%
    Unusual Whales·
    US
    YCBD
    +3.17%
    © 2025 Longbridge｜Disclaimer